Intergroup LEAP trial (S1612): A randomized phase 2/3 platform trial to test novel therapeutics in medically less fit older adults with acute myeloid leukemia
Publisher: John Wiley & Sons Inc
E-ISSN: 1096-8652|93|2|E49-E52
ISSN: 0361-8609
Source: AMERICAN JOURNAL OF HEMATOLOGY, Vol.93, Iss.2, 2018-02, pp. : E49-E52
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.